Total Payments
$7,252
2023 Payments
$252.04
Companies
31
Transactions
209
Medicare Patients
932
Medicare Billing
$71,750
Payment Breakdown by Category
Food & Beverage$3,910 (53.9%)
Consulting$2,700 (37.2%)
Travel$498.62 (6.9%)
Other$117.90 (1.6%)
Education$25.48 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,910 | 197 | 53.9% |
| Consulting Fee | $2,700 | 1 | 37.2% |
| Travel and Lodging | $498.62 | 2 | 6.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $117.90 | 7 | 1.6% |
| Education | $25.48 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $3,650 | 14 | $0 (2022) |
| AbbVie Inc. | $638.96 | 33 | $0 (2023) |
| Allergan, Inc. | $349.14 | 15 | $0 (2022) |
| Biogen, Inc. | $329.16 | 19 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $317.57 | 19 | $0 (2023) |
| GENZYME CORPORATION | $235.60 | 12 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $183.91 | 11 | $0 (2021) |
| EMD Serono, Inc. | $180.88 | 11 | $0 (2023) |
| Amgen Inc. | $171.71 | 7 | $0 (2022) |
| Lilly USA, LLC | $146.97 | 8 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $252.04 | 12 | AbbVie Inc. ($134.08) |
| 2022 | $724.73 | 40 | ABBVIE INC. ($310.10) |
| 2021 | $659.28 | 39 | AbbVie Inc. ($194.78) |
| 2020 | $566.56 | 33 | Allergan, Inc. ($101.78) |
| 2019 | $906.10 | 45 | Allergan Inc. ($144.97) |
| 2018 | $3,816 | 21 | Alexion Pharmaceuticals, Inc. ($3,522) |
| 2017 | $327.08 | 19 | GENZYME CORPORATION ($61.09) |
All Payment Transactions
209 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: NEUROSCIENCE | ||||||
| 09/29/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug), MAYZENT | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Neurology | ||||||
| 04/01/2023 | Biogen, Inc. | TYSABRI (Biological), AVONEX, VUMERITY | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Neurology | ||||||
| 02/07/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: VACCINES | ||||||
| 02/01/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Neurology | ||||||
| 01/26/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.68 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2023 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Immunology | ||||||
| 01/12/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $19.67 | General |
| Category: Neurology | ||||||
| 01/09/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: NEUROSCIENCE | ||||||
| 01/03/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2022 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $15.03 | General |
| Category: Neurology | ||||||
| 10/06/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: NEUROSCIENCE | ||||||
| 09/29/2022 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Neurology | ||||||
| 09/22/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Migraine | ||||||
| 09/08/2022 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: NEUROSCIENCE | ||||||
| 08/18/2022 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug), MAYZENT | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2022 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug), MAYZENT | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2022 | Avion Pharmaceuticals | Dhivy (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Parkinson's disease | ||||||
| 06/16/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Rare Disease | ||||||
| 06/15/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.05 | General |
| 06/13/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 35 | 37 | $4,847 | $1,718 |
| 2022 | 7 | 221 | 294 | $46,765 | $19,349 |
| 2021 | 10 | 296 | 380 | $73,345 | $24,873 |
| 2020 | 10 | 380 | 475 | $64,026 | $25,809 |
Total Patients
932
Total Services
1,186
Medicare Billing
$71,750
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 35 | 37 | $4,847 | $1,718 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 99 | 135 | $17,613 | $8,550 | 48.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 20 | 30 | $6,411 | $3,126 | 48.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 28 | 28 | $6,411 | $2,748 | 42.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2022 | 14 | 28 | $8,802 | $1,957 | 22.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 30 | 35 | $2,275 | $1,273 | 56.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 17 | 25 | $3,225 | $886.92 | 27.5% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2022 | 13 | 13 | $2,028 | $807.06 | 39.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 87 | 105 | $14,007 | $6,728 | 48.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 22 | 34 | $7,164 | $3,514 | 49.1% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2021 | 14 | 41 | $12,315 | $3,410 | 27.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 22 | 22 | $7,590 | $3,138 | 41.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 21 | 21 | $4,853 | $1,855 | 38.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 40 | 41 | $2,770 | $1,733 | 62.5% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2021 | 34 | 47 | $12,877 | $1,489 | 11.6% |
| 95909 | Nerve transmission studies, 5-6 studies | Facility | 2021 | 26 | 27 | $4,212 | $1,354 | 32.2% |
| 95911 | Nerve transmission studies, 9-10 studies | Facility | 2021 | 13 | 13 | $3,451 | $1,256 | 36.4% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Facility | 2021 | 17 | 29 | $4,106 | $396.19 | 9.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 131 | 168 | $15,471 | $8,556 | 55.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 41 | 41 | $7,910 | $3,757 | 47.5% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2020 | 19 | 44 | $13,134 | $3,507 | 26.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 65 | 65 | $3,682 | $2,295 | 62.3% |
| 95911 | Nerve transmission studies, 9-10 studies | Facility | 2020 | 19 | 19 | $4,921 | $1,744 | 35.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 13 | 14 | $5,768 | $1,422 | 24.7% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2020 | 29 | 42 | $6,101 | $1,379 | 22.6% |
About Dr. Carl Robinson, MD
Dr. Carl Robinson, MD is a Neurology healthcare provider based in Lewiston, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639103997.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carl Robinson, MD has received a total of $7,252 in payments from pharmaceutical and medical device companies, with $252.04 received in 2023. These payments were reported across 209 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,910).
As a Medicare-enrolled provider, Robinson has provided services to 932 Medicare beneficiaries, totaling 1,186 services with total Medicare billing of $71,750. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Lewiston, ME
- Active Since 07/10/2006
- Last Updated 09/08/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1639103997
Products in Payments
- UBRELVY (Drug) $449.59
- QULIPTA (Drug) $277.49
- TYSABRI (Biological) $203.31
- KESIMPTA (Drug) $178.24
- Aimovig (Biological) $171.71
- EMGALITY (Drug) $146.97
- APTIOM (Drug) $129.75
- BOTOX (Drug) $125.00
- AUBAGIO (Drug) $108.12
- GILENYA (Drug) $100.59
- SOLIRIS (Drug) $94.67
- BOTOX (Biological) $88.34
- LEMTRADA (Drug) $87.37
- INGREZZA (Drug) $85.17
- TROKENDI XR (Drug) $77.85
- OCREVUS (Biological) $76.78
- AJOVY (Biological) $76.71
- ACTHAR (Biological) $71.58
- INBRIJA (Drug) $66.05
- Radicava (Drug) $58.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Lewiston
Dr. Baljinder Singh, M.d, M.D
Neurology — Payments: $71,043
Neurology $71,043
Jean Thomas, Md, MD
Neurology — Payments: $6,737
Neurology $6,737
Dr. David Burke, Md, MD
Neurology — Payments: $3,751
Neurology $3,751
Dr. Mark Keane, M.d, M.D
Neurology — Payments: $495.11
Neurology $495.11
Dr. Bradley Truax, M.d, M.D
Neurology
Neurology
Dr. Elizabeth Doherty, M.d, M.D
Neurology
Neurology